Risk of Zika Infection Appears to Be Low for Pregnant Women

Share this content:
Risk of Zika Infection Appears to Be Low for Pregnant Women
Risk of Zika Infection Appears to Be Low for Pregnant Women

WEDNESDAY, May 10, 2017 (HealthDay News) -- U.S. women traveling to areas where the Zika virus is circulating might be less likely to be infected than expected, but risk remains, according to research published in the June issue of Obstetrics & Gynecology.

During the first eight months of 2016, the University of California, Los Angeles, maternity clinic in this study evaluated 185 pregnant women with potential exposure to Zika. About 17 percent of the women had been exposed to Zika during travel to the active transmission area that occurred in Miami-Dade County in Florida during the summer of 2016, the researchers said.

Only one out of 185 pregnant women who visited an active Zika area (Honduras) between January and August 2016 was diagnosed with infection. Doctors closely monitored the patient and her pregnancy; both the child and her amniotic fluid tested negative for Zika. A healthy delivery followed, and at 3 months old the baby shows no sign of Zika-related birth defects. The other women had been potentially exposed during travel to Mexico (44 percent), the Caribbean (16 percent), South America (13 percent), Central America (9 percent), and Asia (1 percent). Two-thirds of the women (67 percent) reported mosquito bites, but only one in 10 said they developed any symptoms that might suggest Zika infection.

About half the women (51 percent) traveled to a Zika risk area after the U.S. Centers for Disease Control and Prevention issued its initial travel advisory in February 2016, the researchers said. The advisory warned pregnant Americans to avoid traveling to countries with active Zika infection, and to undergo testing for potential birth defects regardless of whether they exhibited any symptoms.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »